NPCE vs BMRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NPCE Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neuropace, Inc. Common Stock (NPCE) driven by superior Valuation, Growth & Margin, Momentum & Technical while BMRA counters with relative strength in Options & Structure. Fundamentally, NPCE trades at 138.9x Forward P/E with -11.3% operating margin (-15.5% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, NPCE sits in BREAKDOWN (45th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NPCE Revenue | BMRA Revenue | NPCE Op. Margin | BMRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -46.4% | BMRA |
| FY2020 | $40M | $10M | -31.7% | -41.0% | NPCE |
| FY2021 | $50M | $10M | -52.5% | -104.2% | NPCE |
| FY2022 | $50M | $20M | -89.6% | -24.0% | BMRA |
| FY2023 | $70M | $10M | -41.5% | -135.3% | NPCE |
| FY2024 | $80M | $10M | -27.1% | -117.6% | NPCE |
| FY2025 | $100M | $10M | -16.3% | -96.7% | NPCE |
| FY2026 | N/A | $0M | N/A | -119.5% | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NPCE | BMRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $412.6M | $6.0M | Larger Scale | NPCE |
| Trailing P/E Ratio Valuation | 138.9x | N/M | Lower Multiple | NPCE |
| Forward P/E Ratio Valuation | 138.9x | N/M | Lower Multiple | NPCE |
| Revenue Growth (YoY) Growth | -15.5% | -8.3% | Higher Growth | BMRA |
| Operating Margin (TTM) Profitability | -11.3% | -125.2% | Higher Margin | NPCE |
| Net Profit Margin Profitability | -18.4% | -115.5% | Higher Margin | NPCE |
| Return on Equity (ROE) Capital Efficiency | -106.5% | -113.8% | Higher ROE | NPCE |
| 52-Week Range Position Momentum | 16% ($5โ$20) | 4% ($1โ$3) | Stronger Trend | NPCE |
| Beta / 30D Volatility Risk Regime | 1.32ฮฒ ยท 139% Vol | 0.67ฮฒ ยท 62% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 41.0 / 100 (SELL) | 44.5 / 100 (HOLD) | Higher Composite | BMRA |